{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:40:17Z","timestamp":1792402817744,"version":"4.4.0"},"reference-count":84,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"unspecified","delay-in-days":291,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0B9819N"],"award-info":[{"award-number":["G0B9819N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0266462326104127_sec1\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Orphan drug reimbursement remains a contested area in health technology assessment (HTA), as decision makers must balance limited evidence, high unmet need, patient-relevant value, and affordability. Multi-criteria decision analysis (MCDA) has been proposed to make such trade-offs more explicit and transparent, yet empirical applications in European national HTA settings remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0266462326104127_sec2\" sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed and piloted an MCDA framework for orphan drug reimbursement in Belgium. Candidate criteria were identified through a systematic literature review. A multidisciplinary expert panel (comprising representatives from the national reimbursement agency, sickness funds, patient organizations, pharmaceutical companies, clinicians, and bioethicists) participated in four focus group discussions to select and define criteria. Criterion weights were elicited through a three-round Delphi process. The framework was piloted on four orphan drugs previously appraised in Belgium: ponatinib, pirfenidone, onasemnogene abeparvovec, and metreleptin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0266462326104127_sec3\" sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven quantitative and three qualitative contextual criteria were selected. Unmet medical need received the highest weight, followed by comparative effectiveness and impact on patient-reported outcomes. Onasemnogene abeparvovec achieved the highest overall MCDA score (0.77), followed by metreleptin (0.65), pirfenidone (0.47), and ponatinib (0.39). The pilot also generated policy-relevant insights on criterion design, handling residual uncertainty, separating value assessment from reimbursement feasibility (through cost criteria), and using scores to support\u2013rather than replace\u2013deliberation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0266462326104127_sec4\" sec-type=\"conclusions\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study presents the first MCDA framework for orphan drug reimbursement in Belgium and illustrates how criterion weights and scores can structure committee deliberation, complemented by contextual appraisal, to support more transparent, consistent, and accountable decision making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s0266462326104127","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:45:45Z","timestamp":1792399545000},"source":"Crossref","is-referenced-by-count":0,"title":["Making trade-offs explicit: development and pilot of a Belgian MCDA framework for orphan drug appraisal"],"prefix":"10.1017","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-0706","authenticated-orcid":false,"given":"Alessandra","family":"Blonda","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f950310","id-type":"ROR","asserted-by":"publisher"}],"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Ollendorf","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05wvpxv85","id-type":"ROR","asserted-by":"publisher"}],"name":"Tufts University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Huys","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f950310","id-type":"ROR","asserted-by":"publisher"}],"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Denier","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f950310","id-type":"ROR","asserted-by":"publisher"}],"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Simoens","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05f950310","id-type":"ROR","asserted-by":"publisher"}],"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"S0266462326104127_r64","doi-asserted-by":"publisher","DOI":"10.1016\/0040-1625(79)90007-6"},{"key":"S0266462326104127_r47","doi-asserted-by":"publisher","DOI":"10.1111\/hex.12178"},{"key":"S0266462326104127_r69","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0046"},{"key":"S0266462326104127_r76","doi-asserted-by":"publisher","DOI":"10.1787\/6e5e4c0f-en"},{"key":"S0266462326104127_r16","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133119000239"},{"key":"S0266462326104127_r84","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2018.06.010"},{"key":"S0266462326104127_r33","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2015.1045882"},{"key":"S0266462326104127_r78","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-198"},{"key":"S0266462326104127_r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.1744"},{"key":"S0266462326104127_r59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.971"},{"key":"S0266462326104127_r2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1074512"},{"key":"S0266462326104127_r72","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462320000410"},{"key":"S0266462326104127_r22","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0455-6"},{"key":"S0266462326104127_r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2017.03.009"},{"key":"S0266462326104127_r75","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2017.02.002"},{"key":"S0266462326104127_r82","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2025.00174"},{"key":"S0266462326104127_r61","first-page":"14","article-title":"A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain","volume":"9","author":"Zozaya","year":"2022","journal-title":"Glob Reg Health Technol Assess"},{"key":"S0266462326104127_r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.05.015"},{"key":"S0266462326104127_r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.1729"},{"key":"S0266462326104127_r4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-42"},{"key":"S0266462326104127_r31","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2014.906903"},{"key":"S0266462326104127_r11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05805-2"},{"key":"S0266462326104127_r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.04.1913"},{"key":"S0266462326104127_r44","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-74"},{"key":"S0266462326104127_r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.12.003"},{"key":"S0266462326104127_r12","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3275"},{"key":"S0266462326104127_r13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262864"},{"key":"S0266462326104127_r60","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462318000569"},{"key":"S0266462326104127_r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.2001"},{"key":"S0266462326104127_r48","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0370-z"},{"key":"S0266462326104127_r57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.10.002"},{"key":"S0266462326104127_r73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.07.007"},{"key":"S0266462326104127_r83","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0251-x"},{"key":"S0266462326104127_r41","unstructured":"41. Dodgson, JS , Spackman, M , Pearman, A , Phlips, L. Multi-criteria analysis: a manual [Internet]. Department for Communities and Local Government: London; 2009 [cited 2020 Nov 12]. p. 168. Available from: https:\/\/researchonline.lse.ac.uk\/id\/eprint\/12761"},{"key":"S0266462326104127_r17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01462-0"},{"key":"S0266462326104127_r56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051353"},{"key":"S0266462326104127_r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.01.008"},{"key":"S0266462326104127_r46","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462313000639"},{"key":"S0266462326104127_r62","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108711"},{"key":"S0266462326104127_r20","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-014-0560-1"},{"key":"S0266462326104127_r29","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0139-z"},{"key":"S0266462326104127_r24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.750742"},{"key":"S0266462326104127_r27","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02397-4"},{"key":"S0266462326104127_r63","first-page":"e55215","article-title":"Development of the emirates multi-criteria decision analysis tool for orphan drugs","volume":"16","author":"Alnaqbi","year":"2024","journal-title":"Cureus"},{"key":"S0266462326104127_r66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2011.09.012"},{"key":"S0266462326104127_r21","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0235-x"},{"key":"S0266462326104127_r67","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-021-00271-w"},{"key":"S0266462326104127_r55","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2019.24"},{"key":"S0266462326104127_r53","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3258-9"},{"key":"S0266462326104127_r3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci128"},{"key":"S0266462326104127_r28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902150"},{"key":"S0266462326104127_r37","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00287"},{"key":"S0266462326104127_r40","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1495-4"},{"key":"S0266462326104127_r65","first-page":"08","article-title":"Delphi technique theoretical framework in qualitative research","volume":"3","author":"Habibi","year":"2014","journal-title":"Int J Eng Sci"},{"key":"S0266462326104127_r74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.12.010"},{"key":"S0266462326104127_r14","doi-asserted-by":"publisher","DOI":"10.1080\/08989621.2013.793120"},{"key":"S0266462326104127_r7","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0597-1"},{"key":"S0266462326104127_r81","article-title":"From \u201cPrice controls\u201d to robust public conversation: How CMS can move drug Price negotiation into the light","author":"Ollendorf","year":"2024","journal-title":"Health Aff"},{"key":"S0266462326104127_r68","unstructured":"68. RIZIV. Richtlijnen specialiteit klasse 1 [Internet]. 2024 [cited 2024 Dec 8]. Available from: https:\/\/www.riziv.fgov.be\/nl\/thema-s\/verzorging-kosten-en-terugbetaling\/wat-het-ziekenfonds-terugbetaalt\/geneesmiddelen\/farmaceutische-industrie#richtlijnen-voor-het-indienen-van-ctg-dossiers"},{"key":"S0266462326104127_r5","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-124"},{"key":"S0266462326104127_r77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.04.011"},{"key":"S0266462326104127_r79","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01050-5"},{"key":"S0266462326104127_r70","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-023-00455-6"},{"key":"S0266462326104127_r35","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462317000149"},{"key":"S0266462326104127_r80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.03.018"},{"key":"S0266462326104127_r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.02.008"},{"key":"S0266462326104127_r71","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02359-z"},{"key":"S0266462326104127_r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.03.004"},{"key":"S0266462326104127_r25","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-022-00378-8"},{"key":"S0266462326104127_r23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.631527"},{"key":"S0266462326104127_r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2024.105080"},{"key":"S0266462326104127_r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.06.014"},{"key":"S0266462326104127_r58","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1904861"},{"key":"S0266462326104127_r50","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0388-0"},{"key":"S0266462326104127_r52","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0555-3"},{"key":"S0266462326104127_r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.015"},{"key":"S0266462326104127_r34","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2016.00214"},{"key":"S0266462326104127_r10","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-022-00100-2"},{"key":"S0266462326104127_r9","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0755-5"},{"key":"S0266462326104127_r36","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2018.1414603"},{"key":"S0266462326104127_r45","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1121-6"},{"key":"S0266462326104127_r51","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0340-5"},{"key":"S0266462326104127_r54","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0803-9"},{"key":"S0266462326104127_r39","doi-asserted-by":"publisher","DOI":"10.33612\/diss.206096858"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462326104127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:45:50Z","timestamp":1792399550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462326104127\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0266462326104127"],"URL":"https:\/\/doi.org\/10.1017\/s0266462326104127","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e96"}}